{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:04:16Z","timestamp":1784178256075,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether cardiovascular autonomic neuropathy (CAN) and reduced heart rate variability (HRV) predict the development of distal symmetrical polyneuropathy (DSPN) in individuals with diabetes mellitus (DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 288 individuals with DM (mean age 58.1\u00a0\u00b1\u00a013.4 years, 41.3% women, 78.5% with type 2 diabetes) underwent baseline assessment of CAN using cardiovascular autonomic reflex tests and HRV indices (CVRR, rMSSD, high- and low-frequency power). DSPN was characterized using three definitions: (i) clinical criteria based on symptoms and signs, (ii) the sensory-loss phenotype derived from quantitative sensory testing, and (iii) the Toronto consensus definition requiring abnormal nerve conduction plus symptoms or signs. A total of 194 participants without DSPN at baseline were followed for 3.0\u00a0\u00b1\u00a01.3 years to assess incident DSPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, CAN prevalence was 16.3%, and low HRV indices were present in 18.6\u201340.2% of participants. DSPN prevalence was 27.7%, 17.6%, and 20.8% for definitions (i), (ii), and (iii), respectively. Cross-sectionally, CAN and reduced HRV were associated with DSPN (unadjusted ORs 1.8\u20134.0), with associations largely persisting after adjustment. Incident DSPN occurred at 8.4, 5.7, and 3.3 per 100 person-years. Baseline CAN independently predicted incident DSPN (adjusted HRs 6.20, 3.30, and 7.33 across definitions). Lower rMSSD, HF power, and LF power predicted incident DSPN according to definitions (i) and (iii), whereas reduced CVRR predicted DSPN defined by criteria (ii).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Established CAN is a strong predictor of future DSPN. Reduced HRV provides a practical, accessible alternative marker for identifying individuals at elevated neuropathy risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1880532","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:53Z","timestamp":1784175713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced heart rate variability predicts incident diabetic polyneuropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Dimitrios","family":"Tsilingiris","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"First Department of Internal Medicine, University Hospital of Alexandroupolis, Demokritus University of Thrace","place":["Alexandroupolis, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schmalzridt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Eldesouky","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kalb","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Flegka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"von Rauchhaupt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Hoefer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kopf","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]},{"name":"Department of Internal Medicine 1, Endocrinology & Diabetes, University of L\u00fcbeck","place":["L\u00fcbeck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fleming","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]},{"name":"Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Internal Medicine I, Heidelberg University Hospital","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Herzig","sequence":"additional","affiliation":[{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]},{"name":"Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Internal Medicine I, Heidelberg University Hospital","place":["Heidelberg, Germany"]},{"name":"Institute for Diabetes and Cancer, Helmholtz Center Munich","place":["Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hohneck","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Szendroedi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]},{"name":"Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Translational Diabetes Program, Internal Medicine I, Heidelberg University Hospital","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Kender","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry (Internal Medicine I), University Hospital Heidelberg","place":["Heidelberg, Germany"]},{"name":"German Center for Diabetes Research (DZD)","place":["Munich-Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2014.42588","article-title":"Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy","volume":"10","author":"Kasznicki","year":"2014","journal-title":"Arch Med Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.17925\/use.2006.00.02.1r","article-title":"Diabetic neuropathy and foot complications","volume":"126","author":"Boulton","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06242-0","article-title":"Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management","volume":"67","author":"Eleftheriadou","year":"2024","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-2050","article-title":"Cardiovascular autonomic neuropathy independently predicts incident foot ulcers in people with diabetes: a prospective cohort study","volume":"48","author":"Pallin","year":"2025","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108802","article-title":"The association of diabetic peripheral neuropathy with cardiac autonomic neuropathy in individuals with diabetes mellitus: a systematic review","volume":"38","author":"de Paula","year":"2024","journal-title":"J Diabetes Complications"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00191","article-title":"Predictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes","volume":"5","author":"Tannus","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814567226","article-title":"The degree of autonomic modulation is associated with the severity of microvascular complications in patients with type 1 diabetes","volume":"9","author":"Fleischer","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2010.06.001","article-title":"The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes","volume":"25","author":"Voulgari","year":"2011","journal-title":"J Diabetes Complications"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107844","article-title":"Correlation of cardiac autonomic neuropathy with small and large peripheral nerve function in type 2 diabetes mellitus","volume":"156","author":"Pafili","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.03.015","article-title":"Cardiac autonomic neuropathy in patients with type 2 diabetes mellitus having peripheral neuropathy: a cross-sectional study","volume":"13","author":"Haq","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02062-7","article-title":"The co-existence of sensory and autonomic neuropathy in type 1 diabetes with and without pain","volume":"60","author":"Roikjer","year":"2023","journal-title":"Acta Diabetol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-021-01744-4","article-title":"Quantitative sensory testing can effectively predict cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus","volume":"58","author":"Guo","year":"2021","journal-title":"Acta Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1900\/rds.2015.12.48","article-title":"Risk factors and comorbidities in diabetic neuropathy: an update 2015","volume":"12","author":"Papanas","year":"2015","journal-title":"Rev Diabetes Stud"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v9.i1.1","article-title":"Cardiac autonomic neuropathy: risk factors, diagnosis and treatment","volume":"9","author":"Serhiyenko","year":"2018","journal-title":"World J Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/168264","article-title":"Cardiac autonomic neuropathy measured by heart rate variability and markers of subclinical atherosclerosis in early type 2 diabetes","volume":"2012","author":"Fakhrzadeh","year":"2012","journal-title":"ISRN Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.937701","article-title":"Heart rate variability for the early detection of cardiac autonomic dysfunction in type 1 diabetes","volume":"13","author":"Castiglioni","year":"2022","journal-title":"Front Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12933-025-02666-z","article-title":"Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease","volume":"24","author":"Felicio","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1652","article-title":"Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes","volume":"35","author":"Orlov","year":"2012","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.diabres.2018.03.034","article-title":"Association between diabetic peripheral neuropathy and heart rate variability in subjects with type 2 diabetes","volume":"140","author":"Islam","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1556345","article-title":"25-hydroxyvitamin D as a predictor of reduced heart rate variability in elderly patients with diabetes mellitus","volume":"16","author":"Tang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29580","DOI":"10.1038\/s41598-025-15343-8","article-title":"Cohort profile of the Heidelberg study on diabetes and complications HEIST-DiC","volume":"15","author":"Kliemank","year":"2025","journal-title":"Sci Rep"},{"key":"B23","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use","volume":"93","year":"1996","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-s350","article-title":"Diabetic neuropathy","volume":"122","author":"Ziegler","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000935","article-title":"Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations","volume":"158","author":"Vollert","year":"2017","journal-title":"Pain"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mus.27080","article-title":"Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy","volume":"63","author":"Galosi","year":"2021","journal-title":"Muscle Nerve"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002480","article-title":"Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis","volume":"9","author":"Chowdhury","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.11.2850","article-title":"Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study","volume":"94","author":"Tsuji","year":"1996","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1900\/rds.2015.12.213","article-title":"Simplified diagnosis of cardiovascular autonomic neuropathy in type 2 diabetes using Ewing's battery","volume":"12","author":"Pafili","year":"2015","journal-title":"Rev Diabetes Stud"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2013.04.007","article-title":"An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy","volume":"58","author":"Stranieri","year":"2013","journal-title":"Artif Intell Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2307\/2530931","article-title":"An improved method for measuring heart-rate variability: assessment of cardiac autonomic function","volume":"40","author":"Weinberg","year":"1984","journal-title":"Biometrics"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1880532\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:54Z","timestamp":1784175714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1880532\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1880532"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1880532","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1880532"}}